135 related articles for article (PubMed ID: 35118684)
1. Pediatric and Adult Placebo Response Rates in Placebo-Controlled Clinical Trials Submitted to the US Food and Drug Administration 2012-2020.
Park K; Tran NK; Momper JD; Green DJ; Burckart GJ
J Clin Pharmacol; 2022 Aug; 62(8):970-982. PubMed ID: 35118684
[TBL] [Abstract][Full Text] [Related]
2. Ethical Considerations for Pediatric Placebo-Controlled Trials: FDA Outcomes and Perspectives.
Momper JD; Green DJ; Park K; Burckart GJ; Snyder DL
Ther Innov Regul Sci; 2021 Mar; 55(2):282-303. PubMed ID: 32901443
[TBL] [Abstract][Full Text] [Related]
3. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
[TBL] [Abstract][Full Text] [Related]
4. Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents.
Sun H; Bastings E; Temeck J; Smith PB; Men A; Tandon V; Murphy D; Rodriguez W
JAMA Pediatr; 2013 Mar; 167(3):243-9. PubMed ID: 23359002
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Primary Endpoints in Pediatric Efficacy Trials Submitted to the US FDA.
Green DJ; Burnham JM; Schuette P; Liu XI; Maas BM; Yao L; McCune SK; Chen J; van den Anker JN; Burckart GJ
J Clin Pharmacol; 2018 Jul; 58(7):885-890. PubMed ID: 29663424
[TBL] [Abstract][Full Text] [Related]
7. Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012-2018.
Tanaudommongkon I; John Miyagi S; Green DJ; Burnham JM; van den Anker JN; Park K; Wu J; McCune SK; Yao L; Burckart GJ
Clin Pharmacol Ther; 2020 Nov; 108(5):1018-1025. PubMed ID: 32394430
[TBL] [Abstract][Full Text] [Related]
8. Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials.
Hindiyeh NA; Kellerman DJ; Schmidt PC
Headache; 2019 May; 59(5):819-824. PubMed ID: 30953576
[TBL] [Abstract][Full Text] [Related]
9. The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues: An Update From the US Food and Drug Administration.
Gopalakrishnan M; Zhu H; Farchione TR; Mathis M; Mehta M; Uppoor R; Younis I
J Clin Psychiatry; 2020 Mar; 81(2):. PubMed ID: 32141721
[TBL] [Abstract][Full Text] [Related]
10. Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2012 Jun; 73(6):856-64. PubMed ID: 22687813
[TBL] [Abstract][Full Text] [Related]
11. Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 2: data extrapolation, trial design, and pharmacokinetics.
Sun H; Vesely R; Nelson RM; Taminiau J; Szitanyi P; Isaac M; Klein A; Uzu S; Griebel D; Mulberg AE;
J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):684-8. PubMed ID: 24866782
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal Antibodies and Fc-Fusion Proteins for Pediatric Use: Dosing, Immunogenicity, and Modeling and Simulation in Data Submitted to the US Food and Drug Administration.
Liu XI; Dallmann A; Wang YM; Green DJ; Burnham JM; Chiang B; Wu P; Sheng M; Lu K; van den Anker JN; Burckart GJ
J Clin Pharmacol; 2019 Aug; 59(8):1130-1143. PubMed ID: 30865317
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
14. Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of U.S. legislation.
Benning TJ; Shah ND; Inselman JW; Van Houten HK; Ross JS; Wyatt KD
Clin Trials; 2021 Dec; 18(6):732-740. PubMed ID: 34269090
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Drug Development Studies for Familial Hypercholesterolemia Submitted to the US Food and Drug Administration Between 2007 and 2020.
Park K; Vishnevetskaya K; Vaidyanathan J; Burckart GJ; Green DJ
J Clin Pharmacol; 2022 Mar; 62(3):397-408. PubMed ID: 34562277
[TBL] [Abstract][Full Text] [Related]
16. Does the increasing placebo response impact outcomes of adult and pediatric ADHD clinical trials? Data from the US Food and Drug Administration 2000-2009.
Khan A; Fahl Mar K; Brown WA
J Psychiatr Res; 2017 Nov; 94():202-207. PubMed ID: 28755620
[TBL] [Abstract][Full Text] [Related]
17. Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis.
Stone MB; Yaseen ZS; Miller BJ; Richardville K; Kalaria SN; Kirsch I
BMJ; 2022 Aug; 378():e067606. PubMed ID: 35918097
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of anti-manic agents in children and adults.
Khan A; Faucett J; Emslie GJ; Brown WA
Isr J Psychiatry Relat Sci; 2012; 49(2):122-7. PubMed ID: 22801291
[TBL] [Abstract][Full Text] [Related]
19. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
[TBL] [Abstract][Full Text] [Related]
20. Magnitude and Pattern of Placebo Response in Clinical Trials of Oral Antihyperglycemic Agents: Data From the U.S. Food and Drug Administration, 1999-2015.
Khan A; Fahl Mar K; Schilling J; Brown WA
Diabetes Care; 2018 May; 41(5):994-1000. PubMed ID: 29363537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
